Related Experiment Video

Updated: Jun 5, 2025

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
07:08

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

5.6K

Role of silent mutations in KRAS -mutant tumors

Jun Lu1,2,3,4, Chao Zhou1, Feng Pan1

  • 1Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.

Chinese Medical Journal
|December 10, 2024
PubMed

Insights

Silent mutations in the Kirsten-RAS (KRAS) gene, though not changing proteins, impact cancer development. Further research into these KRAS silent mutations is vital for personalized cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Silent mutations in the Kirsten-RAS (KRAS) gene are increasingly recognized for their role in tumorigenesis.
  • While oncogenic KRAS mutations are well-studied, the functional impact of silent KRAS mutations remains less understood.
  • Silent mutations do not alter amino acid sequences but can influence RNA stability and translation.

Purpose of the Study:

  • To synthesize current knowledge on KRAS silent mutations and their contribution to cancer development.
  • To highlight the potential diagnostic and therapeutic implications of these mutations in KRAS-mutant tumors.
  • To underscore the importance of further research bridging basic science and clinical applications.

Main Methods:

  • Literature review and synthesis of existing research on KRAS silent mutations.
  • Analysis of the molecular mechanisms by which silent mutations affect gene expression.
  • Examination of clinical data and studies related to KRAS silent mutations in cancer patients.

Main Results:

  • Silent KRAS mutations can impact RNA stability and translational efficiency, potentially influencing tumor biology.
  • Understanding these mutations is crucial for a comprehensive view of KRAS-driven oncogenesis.
  • Early investigations suggest potential diagnostic and therapeutic strategies related to KRAS silent mutations.

Conclusions:

  • KRAS silent mutations represent an understudied area with significant implications for cancer development.
  • Further exploration is needed to fully elucidate their role in oncogenesis and clinical outcomes.
  • Research into KRAS silent mutations holds promise for advancing personalized cancer treatment strategies.

More Related Videos

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging04:43

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

Published on: February 27, 2020

6.7K
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

8.5K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Mutations01:39

Mutations

Overview
80.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K